![]() |
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Candidiasis is one of the major fungal infections among hospitalized and immunocompromised patients. Identification of Candida upto species level is required as there is increase in the incidence of non albican Candida infections. Increased incidence of antifungal resistance has also been reported. Hence, this study was aimed at speciation of candida and their antifungal susceptibility from clinical specimens. A total of 93 Candida isolated from various clinical specimens. Candida Speciation was performed using CHROM agar and conventional methods. Antifungal susceptibility test was performed as per CLSI recommendations in document M44-A. Candida albicans (39.78%) was found to be the predominant species isolated from clinical specimens followed by non albican candida. Among non albican candida, C.tropicalis (22.58%) was predominant species isolated. C.albicans (45.95%) and C.tropicalis(38.09%) showed least sensitivity towards azole group. Majority of isolates remained susceptible to Amphotericin B. Candida albicans was found to be the predominant species isolated from clinical specimens. Among non albicans candida, Candida tropicalis was the predominant species isolated. Candida tropicalis was least sensitive to azoles followed by Candida albicans.
![]() |
![]() |
![]() |
![]() |
![]() |